These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33269535)

  • 1. Association of weight loss and weight loss maintenance following diabetes diagnosis by screening and incidence of cardiovascular disease and all-cause mortality: An observational analysis of the ADDITION-Europe trial.
    Strelitz J; Sharp SJ; Khunti K; Vos RC; Rutten GEHM; Webb DR; Witte DR; Sandbaek A; Wareham NJ; Griffin SJ
    Diabetes Obes Metab; 2021 Mar; 23(3):730-741. PubMed ID: 33269535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.
    Strelitz J; Ahern AL; Long GH; Hare MJL; Irving G; Boothby CE; Wareham NJ; Griffin SJ
    Diabetologia; 2019 Aug; 62(8):1391-1402. PubMed ID: 31062041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials.
    Strelitz J; Lawlor ER; Wu Y; Estlin A; Nandakumar G; Ahern AL; Griffin SJ
    Diabetologia; 2022 Mar; 65(3):424-439. PubMed ID: 34859263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
    Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.
    Moazzeni SS; Hizomi Arani R; Deravi N; Hasheminia M; Khalili D; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2021 Jul; 20(1):141. PubMed ID: 34253199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.
    Strelitz J; Ahern AL; Long GH; Boothby CE; Wareham NJ; Griffin SJ
    Cardiovasc Diabetol; 2019 Aug; 18(1):98. PubMed ID: 31370851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.
    Simmons RK; Carlsen AH; Griffin SJ; Charles M; Christiansen JS; Borch-Johnsen K; Sandbaek A; Lauritzen T
    Diabet Med; 2014 Dec; 31(12):1577-85. PubMed ID: 25185778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
    Simmons RK; Bruun NH; Witte DR; Borch-Johnsen K; Jørgensen ME; Sandbæk A; Lauritzen T
    Diabetologia; 2017 Jun; 60(6):1016-1021. PubMed ID: 28280901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective Study.
    Bae JC; Cho NH; Kim JH; Hur KY; Jin SM; Lee MK
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):416-424. PubMed ID: 32615726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
    Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
    Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study.
    Deravi N; Moazzeni SS; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
    BMC Public Health; 2022 Sep; 22(1):1762. PubMed ID: 36114528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study.
    Kim MK; Han K; Koh ES; Kim ES; Lee MK; Nam GE; Kwon HS
    Cardiovasc Diabetol; 2019 Mar; 18(1):36. PubMed ID: 30890169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease.
    Bancks MP; Akhabue E; Rana JS; Reis JP; Schreiner PJ; Yano Y; Lewis CE
    Diabetes Res Clin Pract; 2020 Aug; 166():108334. PubMed ID: 32702469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight change is associated with increased all-cause mortality and non-cardiac mortality among patients with type 2 diabetes mellitus.
    Xing Z; Pei J; Huang J; Peng X; Chen P; Hu X; Gao S
    Endocrine; 2019 Apr; 64(1):82-89. PubMed ID: 30864142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cardiovascular disease risk by health behaviour change following type 2 diabetes diagnosis.
    Estlin AFL; Ahern AL; Griffin SJ; Strelitz J
    Diabet Med; 2021 Oct; 38(10):e14646. PubMed ID: 34270827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years.
    Williamson DF; Pamuk E; Thun M; Flanders D; Byers T; Heath C
    Am J Epidemiol; 1999 Mar; 149(6):491-503. PubMed ID: 10084238
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.